How Can Molecular Biologists Contribute to New Cancer Therapies?
Molecular biologists contribute to new cancer therapies by identifying biomarkers that can be targeted by drugs. For example, the development of immune checkpoint inhibitors was based on the understanding of molecular pathways that regulate the immune response to cancer. Additionally, they work on gene therapy approaches to correct genetic defects and employ RNA interference (RNAi) to silence specific genes involved in cancer progression. These contributions are essential for the development of innovative and effective treatments.
